Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DART: "Sivextro® in Acute Bacterial Skin anD Skin Structure Infection (ABSSSI) in Hospitalized Patients. A Global ObseRvational STudy."

NCT02991131 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT02991131
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02991131 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DART: "Sivextro® in Acute Bacterial Skin anD Skin Structure Infection (ABSSSI) in Hospitalized Patients. A Global ObseRvational STudy."
Lead sponsor
Bayer
Phase
Observational
Overall status
Terminated
Start date
December 17, 2016
Completion date
November 21, 2018
Enrollment
108 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

skin disease, infectious